Inclusion Criteria:  Older than 18 years HIV-1 infected subjects. Switched to a doravirine-based ART regimen under clinician criteria.  Exclusion Criteria:  Doravirine major resistance mutations (accessory mutations are allowed). Major mutations to any of the other drugs combined with doravirine. Pregnancy, active tuberculosis or any condition that contraindicate the use of doravirine.